NCT03091452

Brief Summary

CASE AF aims to describe the reality of medical care of patients in whom atrial fibrillation is treated by cardiac surgical ablation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
43mo left

Started Jan 2017

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress72%
Jan 2017Dec 2029

Study Start

First participant enrolled

January 1, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 13, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 27, 2017

Completed
11.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Last Updated

December 24, 2025

Status Verified

October 1, 2025

Enrollment Period

11.9 years

First QC Date

March 13, 2017

Last Update Submit

December 17, 2025

Conditions

Atrial Fibrillation

Outcome Measures

Primary Outcomes (1)

  • Number of major bleeding events

    Documentation of procedural results and clinical short-and long-term results of the documented therapies

    12 months

Secondary Outcomes (2)

  • Number of major adverse cardiac events

    12 months

  • Complications during hospital stay

    12 months

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients in whom atrial fibrillation is treated by cardiac surgical ablation

You may qualify if:

  • Atrial fibrilation
  • Treated by cardiac surgical ablation

You may not qualify if:

  • Patient denies participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Klinikum Bogenhausen

München, Bavaria, 81925, Germany

RECRUITING

Asklepios Harburg

Hamburg, Hamburg, 21075, Germany

NOT YET RECRUITING

Schüchtermann Kliniken

Bad Rothenfelde, North Rhine-Westphalia, 49214, Germany

RECRUITING

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Thorsten Hanke, MD

    Asklepios Hamburg Harburg

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Belgin Özdemir

CONTACT

00496215032888oezdemir@stiftung-ihf.de

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 13, 2017

First Posted

March 27, 2017

Study Start

January 1, 2017

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2029

Last Updated

December 24, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations

DE(3)